HOME WHO WE ARE ACCORD ITALY ACCORD EUROPE INTAS GROUP PRODUCTS INJECTABLE ORAL PHARMASHIELD RESOURCES BEES R&D CRO REGULATORY PRODUCTION SUPPLY QUALITY SALES & MARKETING PHARMACOVIGILANCE NEWS CONTACTS SIGN IN RESERVED MATERIAL CHANGE OF OPERATIONAL OFFICE To organically support the growth of the company, we are pleased to announce the transfer of the offices to the new headquarters in Viale Monza 265 - 20126 Milan. All new company references are available in the 'Contacts' section. Go to the Contacts page REALLY MULTINATIONAL Part of the Intas group, Accord Healthcare is a young and dynamic pharmaceutical company engaged in the development, production and distribution of pharmaceutical products in over 50 world markets. A COMPLETE APPROACH The group aims to be the protagonist in all the phases that allow pharmaceutical products to reach patients. Today, the businesses integrate the entire production chain of a drug's value, thus creating a truly integrated offering. EUROPEAN FOCUS Accord currently has a portfolio of almost 5,000 products authorized throughout Europe: a strong European commercial footprint, with a direct presence in all major EU markets. CAPECITABINA ACCORD 500MG 120 TABLETS - UNIT DOSE Accord Healthcare Italia is pleased to announce the new Unit Dose packaging of CAPECITABINA ACCORD 500MG 120 TABLETS. Read everything ACCORD ONCOLOGICAL APP Accord OncoLogical App is now available on Apple Store and Google Play. Read everything PACLITAXEL ACCORD 600MG Accord Healthcare Italia is pleased to announce the arrival on the market of a new dosage of Paclitaxel: Paclitaxel Accord 600mg. Read everything Report an adverse event >> Copyright Accord Healthcare

Home Resources Sales and Marketing HOME WHO WE ARE ACCORD ITALY ACCORD EUROPE INTAS GROUP PRODUCTS INJECTABLE ORAL PHARMASHIELD RESOURCES BEES R&D CRO REGULATORY PRODUCTION SUPPLY QUALITY SALES & MARKETING PHARMACOVIGILANCE NEWS CONTACTS SIGN IN RESERVED MATERIAL SALES & MARKETING Accord Healthcare is young, dynamic, free from the ways of operating of the past and determined to make a big impact. We currently have commercial activities in more than 30 European countries and we expect to be able to count on a commercial presence in all European markets. To date we have acquired over 4,500 authorized products in the European Economic Area. Our strategy is to be involved in all aspects that make it possible to bring drugs to patients, starting from their clinical concept up to their administration to end users. By controlling all stages of the process, Accord is able to deliver high quality medications to patients faster, cheaper and more efficiently than its rivals. Copyright Accord Healthcare